The European Union and Nigeria have entered into a collaborative agreement worth €18 million to improve research and development in Nigeria, aimed at implementing Nigeria’s national plan for pharmaceutical industry advancement and local production of vaccines and medical technologies.
The agreement was made official by Jutta Urpilainen, who represents the European Union, and Didi Walson-Jack, a top official from Nigeria’s Ministry of Education, during the EU Global Gateway high-level event on education held in Brussels on Thursday.
Modestu Chukwulaka, the EU’s Head of Communication, stated on Friday that this partnership highlights the EU’s strong commitment to promoting educational and health equity.
He said it shows how committed the EU is to making sure everyone has equal access to education and healthcare.
“Our investments in quality education, research, and training aim to empower future generations by equipping them with the knowledge, skills, and competencies necessary to confront global challenges and foster prosperity.”
The EU is giving €18 million to Nigeria as part of its plan to improve manufacturing and access to vaccines and medicine in Africa. This money will be used to improve different parts of Nigeria’s pharmaceutical sector.
This support includes things like training people, doing research to come up with new medicines and technologies, using advanced technology like artificial intelligence and nanotechnology, and making the system for getting and distributing medical products better. They also want to make it easier for trade and investment in this sector.
